Jesse C Ikeme (Jesse Ikeme)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Ejection Fraction

Placebo Controlled

Top Venues

American journal of hypertension

Clinical journal of the American Society of Nephrology : CJASN

This page only lists publications with an associated author ORCID identifier.

Publications

Jesse C Ikeme, Erin Madden, Julio Alejandro Lamprea-Montealegre, Chi D Chu, Michael G Shlipak, Ian Ellis McCoy, Michelle M Estrella
Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans. Clinical journal of the American Society of Nephrology : CJASN (2024)
Jesse C Ikeme, Ronit Katz, Anthony N Muiru, Michelle M Estrella, Rebecca Scherzer, Pranav S Garimella, Stein I Hallan, Carmen A Peralta, Joachim H Ix, Michael G Shlipak
Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial. American journal of hypertension 35 (12) (2022)
Jesse C Ikeme, Ronit Katz, Anthony N Muiru, Michelle M Estrella, Rebecca Scherzer, Pranav S Garimella, Stein I Hallan, Carmen A Peralta, Joachim H Ix, Michael G Shlipak
Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial. American journal of hypertension 35 (12) (2022)
Jesse C Ikeme, Ronit Katz, Anthony N Muiru, Michelle M Estrella, Rebecca Scherzer, Pranav S Garimella, Stein I Hallan, Carmen A Peralta, Joachim H Ix, Michael G Shlipak
Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial. American journal of hypertension 35 (12) (2022)
Jesse C Ikeme, Ronit Katz, Anthony N Muiru, Michelle M Estrella, Rebecca Scherzer, Pranav S Garimella, Stein I Hallan, Carmen A Peralta, Joachim H Ix, Michael G Shlipak
Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial. American journal of hypertension 35 (12) (2022)